The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a ...

Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

Within six months, the drug reduced the risk of cardiovascular death by 50% and cut the risk of needing urgent treatment due ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

President Trump shared a story about a businessman friend's frustration with the high cost of a weight-loss drug in the U.S.

Weight loss drugs have been pitted against each other in a first of its kind head-to-head trial. Mounjaro and Wegovy were put ...